Search

Displaying results 2461 - 2470 of 9714 in total
  1. Drug

    Phenacaine

    go.drugbank.com/drugs/DB21274
    Experimental

    Phenacaine is a small molecule drug. The usage of the INN stem '-caine' in the name indicates that Phenacaine is a local anaesthetic. Phenacaine has a monoisotopic molecular weight of 298.17 Da.

  2. Drug

    Uldazepam

    go.drugbank.com/drugs/DB21290
    Experimental

    Uldazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Uldazepam is a diazepam derivative. Uldazepam has a monoisotopic molecular weight of 359.06 Da.

  3. Drug

    Fluradoline

    go.drugbank.com/drugs/DB21333
    Experimental

    Fluradoline is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Fluradoline is a analgesic. Fluradoline has a monoisotopic molecular weight of 301.09 Da.

  4. Drug

    Pinoxepin

    go.drugbank.com/drugs/DB21397
    Experimental

    Pinoxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Pinoxepin is a tricyclic compound. Pinoxepin has a monoisotopic molecular weight of 398.18 Da.

  5. Drug

    Ruzadolane

    go.drugbank.com/drugs/DB21444
    Experimental

    Ruzadolane is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Ruzadolane is a analgesic. Ruzadolane has a monoisotopic molecular weight of 375.13 Da.

  6. Drug

    Lactobacillus coryniformis K8

    go.drugbank.com/drugs/DB15733
    Experimental

    Lactobacillus is a common bacteria found in the gut with Lactobacillus coryniformis K8 being originally isolated from artisan goat cheese.

    Synonyms: Lc K8
  7. Drug

    AK106-001616

    go.drugbank.com/drugs/DB16058
    Investigational

    AK106-001616 is under investigation in clinical trial NCT01285752 (A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)).

  8. Drug

    LY-3200882

    go.drugbank.com/drugs/DB16064
    Investigational

    LY-3200882 is under investigation in clinical trial NCT04158700 (A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer).

  9. Drug

    Benmelstobart

    go.drugbank.com/drugs/DB17473
    Investigational

    APL 502 is a humanised immunoglobulin G1 (IgG1) monoclonal antibody targeting the programmed cell death-1 ligand-1 (PD-L1).

  10. Drug

    DTx-1252

    go.drugbank.com/drugs/DB18086
    Experimental

    DTx-1252 is a siRNA therapeutic under investigation for the treatment of Charcot-Marie-Tooth Disease type 1A (CMTD1A).[L48096]